Companies similar to MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Health Care · NASDAQ
MADRIGAL PHARMACEUTICALS, INC. (MDGL)'s closest peers include NOVO NORDISK A S (NVO), Lilly (Eli) (LLY) and Viking Therapeutics (VKTX). This peer set is drawn from MDGL's enriched company profile and is informational only — not financial advice.
Similar companies
-
NOVO NORDISK A SNVO
Global healthcare leader pioneering breakthrough diabetes and chronic disease treatments with heritage spanning a century.
$50.32 (as of 2026-07-17) · market cap $1.12T
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,179.11 (as of 2026-07-17) · market cap $1.11T
-
Viking TherapeuticsVKTXHealth Care
Viking is developing VK2735, a novel dual GLP-1/GIP receptor agonist in Phase 3 trials for obesity and metabolic disorders, targeting a high-growth market…
$37.08 (as of 2026-07-17) · market cap $4.3B
Not quite? Describe exactly what you want →
Peers are drawn from MDGL's enriched profile (the same similarity signal the chat uses for "companies like MDGL"). See the full profile: MADRIGAL PHARMACEUTICALS, INC. (MDGL).
Last updated 2026-07-17.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.